Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry Posted on September 28th, 2022 by LEADconnection Post navigation Previous: Lead-related superior vena cava syndrome: Management and outcomesNext: Defibrillator Lead Survival: Where Is the Threshold?
Lead-related superior vena cava syndrome: Management and outcomes Posted on September 28th, 2022 by LEADconnection Post navigation Previous: Transvenous management of cardiac implantable electronic device late lead perforation.Next: Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry
Transvenous management of cardiac implantable electronic device late lead perforation. Posted on September 28th, 2022 by LEADconnection Post navigation Previous: Outcomes of cardiac implantable electronic device transvenous lead extractions performed in centers without onsite cardiac surgeryNext: Lead-related superior vena cava syndrome: Management and outcomes